State Of Wisconsin Investment Board Atai Life Sciences N.V. Transaction History

State Of Wisconsin Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.27 - $2.28 $19,277 - $34,608	15,179 New	15,179 $19,000
Q1 2023 May 15, 2023	SELL	$1.17 - $2.7 $115,408 - $266,328	-98,640 Reduced 86.27%	15,704 $28,000
Q4 2022 Feb 14, 2023	SELL	$2.38 - $3.55 $17,140 - $25,567	-7,202 Reduced 5.93%	114,344 $304,000
Q3 2022 Nov 14, 2022	SELL	$3.14 - $4.87 $21,132 - $32,775	-6,730 Reduced 5.25%	121,546 $402,000
Q2 2022 Aug 15, 2022	BUY	$3.03 - $5.32 $388,676 - $682,428	128,276 New	128,276 $467,000

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

Stay updated on State Of Wisconsin Investment Board with notifications on news.